Rupnow BA - Search Results

1

Modulation of c-Myc activity and apoptosis in vivo.

Alarcon RM, Rupnow BA, Graeber TG, Knox SJ, Giaccia AJ. Alarcon RM, et al. Among authors: rupnow ba. Cancer Res. 1996 Oct 1;56(19):4315-9. Cancer Res. 1996. PMID: 8813114

2

Association of BCL-2 with membrane hyperpolarization and radioresistance.

Gilbert MS, Saad AH, Rupnow BA, Knox SJ. Gilbert MS, et al. Among authors: rupnow ba. J Cell Physiol. 1996 Jul;168(1):114-22. doi: 10.1002/(SICI)1097-4652(199607)168:1<114::AID-JCP14>3.0.CO;2-7. J Cell Physiol. 1996. PMID: 8647905

3

Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.

Rupnow BA, Murtha AD, Alarcon RM, Giaccia AJ, Knox SJ. Rupnow BA, et al. Cancer Res. 1998 May 1;58(9):1779-84. Cancer Res. 1998. PMID: 9581811

4

Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor.

Rupnow BA, Murtha AD, Chen E, Knox SJ. Rupnow BA, et al. Cancer Lett. 1998 May 15;127(1-2):211-9. doi: 10.1016/s0304-3835(98)00045-7. Cancer Lett. 1998. PMID: 9619879 Free article.

5

p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts.

Rupnow BA, Alarcon RM, Giaccia AJ, Knox SJ. Rupnow BA, et al. Cell Death Differ. 1998 Feb;5(2):141-7. doi: 10.1038/sj.cdd.4400328. Cell Death Differ. 1998. PMID: 10200458

6

Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University.

Murtha AD, Rupnow BA, Hansosn J, Knox SJ, Hoppe R. Murtha AD, et al. Among authors: rupnow ba. Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):3-15. doi: 10.1016/s0360-3016(00)00780-x. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163492

7

The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy.

Rupnow BA, Knox SJ. Rupnow BA, et al. Apoptosis. 1999 Apr;4(2):115-43. doi: 10.1023/a:1009675028784. Apoptosis. 1999. PMID: 14634289

8

Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.

Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li A, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA, Wong TW. Carboni JM, et al. Among authors: rupnow ba. Cancer Res. 2005 May 1;65(9):3781-7. doi: 10.1158/0008-5472.CAN-04-4602. Cancer Res. 2005. PMID: 15867374

9

Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine).

Gilbert MS, Rupnow BA, Ramirez DA, Trisler KD, Knox SJ. Gilbert MS, et al. Among authors: rupnow ba. Cell Death Differ. 1996 Apr;3(2):215-22. Cell Death Differ. 1996. PMID: 17180085

10

Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.

Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, Henley BJ, Yang WP, Zhu J, Madireddi MT, Lawrence RM, Wong TW, Rupnow BA. Roongta UV, et al. Among authors: rupnow ba. Mol Cancer Res. 2011 Nov;9(11):1551-61. doi: 10.1158/1541-7786.MCR-11-0126. Epub 2011 Sep 27. Mol Cancer Res. 2011. PMID: 21954435 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters